Pirates of the Amazon|生物剽窃:合法研究,还是非法剥削?

新建网页 1


by Matthew Brown

Biopiracy is a new problem involving undiscovered species, pharmaceutical companies, and billions of dollars.


More than half of the world's plant and animal species are found in jungles such as the Amazon Rainforest. These regions are paradises for researchers who are looking for new species of plants or animals that might contain useful chemicals. No one knows what incredible life-altering discoveries will be made in these places.


Of course, the discovery of new species can be big business as well, especially when profitable pharmaceuticals are involved. An example is the star anise, a star-shaped seed that contains a valuable chemical extracted for a drug used to slow the spread of influenza. This means that for poor countries with high levels of biodiversity, biological discoveries can be a big boost to their economies.


The discovery of a single plant can also increase the wealth of a company instead of the country. Companies sometimes send researchers to find new species in other countries, which is called bioprospecting. This method is good because useful organisms are discovered, but not good when the companies, only concerned with making money, patent the discoveries for themselves. When this happens, it's labeled biopiracy. Patents are registered not for the plants or animals but for the chemicals derived from them. The result is that the companies, not the countries, control their uses and therefore get all the profit.


Some countries, such as Brazil, have tried to fight back, using laws to prevent researchers from taking samples. This might help Brazil, but it doesn't aid the world in developing new medicines that benefit people. It seems that piracy, an old problem in a new form, will be around for a while.


1.  What is biopiracy?

(A) When companies patent substances found in species from other countries.

(B) The use of chemicals made in other countries to formulate medicine.

(C) When any living thing is smuggled from one country to another.

(D) The article doesn't clearly state what it is.


2.  According to the article, bioprospecting _____.

(A) is always a bad thing

(B) is always a good thing

(C) should be banned in all countries

(D) can be either a good or bad thing


3.  What does the author of the article seem to believe?

(A) All medicines from Brazil should be illegal.

(B) Biopiracy will not be going away anytime soon.

(C) Biopiracy is vital to the discovery of new elements.

(D) Countries should allow biopiracy to flourish for the good of the world.

生物剽窃:合法研究,还是非法剥削?


生物剽窃这种新议题牵扯到尚未发现的物种、制药厂商和几十亿的商机。


  世界上超过一半的动植物物种都是在亚马逊雨林等丛林中所发现。对正在寻找包含有用化学物质的新动植物物种的科学家而言,这些地方就如同天堂一般。没有人知道这里会有什么改变生命的惊奇发现。


  当然,新物种的发现也可能是个巨大的商机,尤其是当中牵扯到有利润的药物时。其中一个例子是八角,这是一种星形的植物果实,能萃取到某种珍贵化学物质,用来制造减缓流感传染速度的药物。这意味着对拥有高度生物多样性的贫穷国家来说,生物上的新发现对当地经济而言是一大帮助。


  单一植物的发现也能为公司赚进大把钞票,但产地国并未从中得利。公司有时会派研究员到他国寻找新的物种,这种行为称为生物勘探。这个方法有其好处,因为有用的生物体会被发掘,但当公司只关心赚钱,为自己的发现申请专利时,生物勘探就没那么正面了。当这种情况发生时,就被称为生物剽窃。公司所登记的专利并非是植物或动物本身,而是从中萃取出的化学物质。结果控制使用权,并因此获得所有利润的是公司而非产地国。


  像巴西等有些国家已经开始试图反击,利用法律来阻止研究人员采集样本。这或许能帮上巴西一点忙,但无法帮助世界开发新的药物来造福人类。看来剽窃这个老问题,将会以新的型态继续存在好一阵子。


答案:1. (A)2. (D)3. (B)


巴西在 2011 年,对利用当地物种生产如药品之类产品而没有告知政府的公司,按法律规定采取行动。巴西环境与再生自然资源所(IBAMA)环境监督检验机构负责人布鲁诺‧巴博萨(Bruno Barbosa)表示:『巴西自 2010 年 7月以来,针对被指控使用原产于巴西的动植物却不支付合理补偿的公司,已开出总计一百多万雷亚尔(5,900万美元)的罚款。』2011 年每笔罚款可能上升至 290万美元,而且稽查员若发现公司没有确实注册使用本地物种,可能面临被取消在巴西的专利。


不过批评人士说,巴西大力度防止生物剽窃的举措,往往产生减缓对当地居民可能提供新的癌症或疾病疗法关键性科学研究的威胁。(数据源:台湾环境信息协会)




0

播放音频

Pirates of the Amazon|生物剽窃:合法研究,还是非法剥削?

开心一读